Tom Creveling

Tom Creveling is currently the Executive Director of Global Pricing, Reimbursement and Access at Eli Lilly and Company, specializing in the US, EU, Australia, and Canada markets. They previously served in various roles at Eli Lilly, including Director for Pricing, Reimbursement and Access for Internal Medicines Brands, and developed global strategies for multiple product launches. Tom's earlier experience includes working as an Analyst at Duke Realty Corporation from 1998 to 2000. They hold a BA in Art History from Indiana University Bloomington and pursued further studies at the Kelley School of Business.